跳至主要内容
临床试验/CTRI/2025/08/093378
CTRI/2025/08/093378尚未招募2 期

Clinical Trial to Access the Efficacy of Shirodhara & Suvarnaprasan in Autism & Establishment of Center for Autism

Banaras Hindu University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
ESR

研究概览

简要总结

In Ayurveda, the condition Autism may be understood on the lines of Unmad in a lesser degree and can be categorized as a minor psychological ailment of the child. Unmad is a clinical condition characterized by indecisiveness (Dhee Vibram) and unstable mind (Satwapariplawa), looking elsewhere usually by avoiding eye contact (Paryakuladrishti), lack of courage (Adheerata) incoherent and indistinct talk. (Abaddha Avaya) and lack of insight or imagination due to inability to process sensory information (Hridayamcha Shoonyam), when these symptoms exist in a minor form it could be considered as autistic behaviour.

SUVARNAPRASANA - Administration of colloidal gold using fine particles of metallic gold or suvarna bhasma has been advised in Ayurveda in infants and children in various forms. Suvarnaprashana described in Kashyapa Samhita is intended to boost memory, intelligence and immunity in infants. It is one of the oldest applications of gold nano medicine. Suvarnaprashana therapy is becoming widely popular and being administered on the Pushya nakshatra of every month at Ayurveda centers across India. Clinical and pharmacological studies show immunomodulatory, no tropic as well as therapeutic effects of Suvarnaprashana therapy

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 10.00 Year(s)(—)
性别
All

入选标准

  • Children aged 3 to 10 years satisfying M CHART Scale criteria.
  • Patient diagnosed as autism irrespective of sex, religion, etc.
  • will be included in the study.

排除标准

  • Children with physical disability 18 • Children with psychiatric illness.
  • • Children with gross brain damage causing mental retardation.
  • • Children with any genetic disorder • Unreliable history.

结局指标

主要结局

ESR

时间窗: Before intervention | Then after 60th Day

Syrum IgG

时间窗: Before intervention | Then after 60th Day

IQ Test

时间窗: Before intervention | Then after 60th Day

Anthropometry

时间窗: Before intervention | Then after 60th Day

CBC

时间窗: Before intervention | Then after 60th Day

次要结局

  • Improvement in criteria in the scale for(State of appetite)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Shekhar Singh

Institute Of Medical Science Banaras Hindu University Varanasi

研究点 (1)

Loading locations...

相似试验